0001181431-13-032683.txt : 20130604 0001181431-13-032683.hdr.sgml : 20130604 20130604200245 ACCESSION NUMBER: 0001181431-13-032683 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130603 FILED AS OF DATE: 20130604 DATE AS OF CHANGE: 20130604 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11119 NORTH TORREY PINES ROAD STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-550-7500 MAIL ADDRESS: STREET 1: 11119 NORTH TORREY PINES ROAD STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FOEHR MATTHEW W CENTRAL INDEX KEY: 0001237556 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33093 FILM NUMBER: 13892919 MAIL ADDRESS: STREET 1: 11085 NORTH TORREY PINES RD #300 CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 rrd382315.xml FORM 4 - MATT FOEHR 6-3-2013 X0306 4 2013-06-03 0 0000886163 LIGAND PHARMACEUTICALS INC LGND 0001237556 FOEHR MATTHEW W 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 0 1 0 0 EVP and COO Common Stock 2013-06-03 4 A 0 8333 0 A 43870 D These shares are represented by restricted stock units, which will vest on April 18, 2014, subject to the Reporting Person's continued status as an employee, director or consultant to the Company or its subsidiaires on each such date. By: John P. Sharp For: Matthew W. Foehr 2013-06-04